
动脉粥样硬化免疫治疗的临床研究进展
网络出版日期: 2017-07-05
基金资助
国家自然科学基金(81470390);上海市教育委员会高峰高原学科建设计划(20152218)
Clinical research progress in immunotherapy against atherosclerosis
Online published: 2017-07-05
Supported by
National Natural Science Foundation of China, 81470390; Shanghai Municipal Education Commission—Gaofeng Clinical Medicine Grant Support, 20152218)
尤纱纱 , 曹惠敏 , 薛晓梅 , 何斌 . 动脉粥样硬化免疫治疗的临床研究进展[J]. 上海交通大学学报(医学版), 2017 , 37(6) : 836 . DOI: 10.3969/j.issn.1674-8115.2017.06.021
Atherosclerosis is a chronic inflammatory disease, with both the innate and adaptive immune systems responding to many endogenous and exogenous antigens. Subsequent investigations have revealed that an immunomodulatory strategy via active immunization against atherosclerotic plaque antigen(s) could potentially alleviate atherosclerosis. Substantial data from clinical investigations support the key role of immune system in atherosclerosis. So, it may be promising to develop immunotherapy against atherosclerosis. The paper reviews current status of immunization studies and possible associated immunemediated inflammatory mechanisms in atherosclerosis.
Key words: atherosclerosis; passive immunization;; vaccine; low-density lipoprotein
/
| 〈 |
|
〉 |